Literature DB >> 31122940

JAK inhibitors and risk of B-cell lymphomas.

Elisa Rumi1,2, Silvia Zibellini2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31122940     DOI： 10.1182/blood-2019-03-900951

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  2 in total

1.  Coexistence of Trisomy 8 and 13 in a Newly Diagnosed Patient With Diffuse Large B Cell Non-Hodgkin Lymphoma and Acute Myeloid Leukemia Secondary to Primary Myelofibrosis.

Authors:  Horia Bumbea; Viola Maria Popov; Ciprian Tomuleasa; Meilin Omer; Camelia Dobrea; Irina Manea; Sabina Zurac; Cristiana Popp; Ion Dumitru; Madalina Simoiu; Bogdan Mastalier
Journal:  Cureus       Date:  2022-02-14

Review 2.  Histone Modifications and Their Targeting in Lymphoid Malignancies.

Authors:  Miranda Fernández-Serrano; René Winkler; Juliana C Santos; Marguerite-Marie Le Pannérer; Marcus Buschbeck; Gaël Roué
Journal:  Int J Mol Sci       Date:  2021-12-27       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.